The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 3 rounds in the feed, most often at Series B and in Biotech.
Venture capitalGreenwich, CT 06830deeptrackcapital.comRounds from 2025-03-17 to 2026-07-14
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Draig A biotech company | Series B Verified against 1 of 3 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $65M | 2026-07-14 | [ LEAD ] |
Tubulis Tubulis develops antibody-drug conjugates for treating various cancers. |
Series C Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. |
| $358.0M |
| 2025-10-15 |
| [ PART ] |
Latigo Biotherapeutics Latigo is a clinical-stage biopharmaceutical company developing innovative non-opioid pain medicines. | Series B Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $150M | 2025-03-17 | [ PART ] |